The future of RNAi in pediatrics is promising, with ongoing research focusing on improving delivery systems, minimizing off-target effects, and ensuring long-term safety. Clinical trials are underway to evaluate the efficacy of RNAi in treating various pediatric conditions, offering hope for new, effective treatments.